TMCnet News

FDA's Ambitious Regulation of Social Media Webinar: How to Manage your Marketing Activity and Gauge what Regulatory Risks your Business is Willing to Accept - ResearchAndMarkets.com
[June 30, 2022]

FDA's Ambitious Regulation of Social Media Webinar: How to Manage your Marketing Activity and Gauge what Regulatory Risks your Business is Willing to Accept - ResearchAndMarkets.com


The "FDA's Ambitious Regulation of Social Media" webinar has been added to ResearchAndMarkets.com's offering.

This webinar will provide insight on how to manage your marketing activity and gauge what regulatory risks your business is willing to accept when it uses social media.

The vehicle for communication has evolved dramatically over the past 100 years and continues to evolve at a rate faster than one can anticipate at times. Through this webinar, participants will learn how to navigate FDA's interpretations and expectations about a firm's marketing practices through social media.

Applying a new guidance and related guidance documents becomes a new test of the FDA's legal boundaries and enforcement options. The agency now applies the princples of cognitive psychology to aid in its determination of what a message really conveys and whether it ultimately violates the law.



Attendees will see how a firm's regulatory profile requires cooperation between marketing, regulatory affairs, legal counsel, manufacturing, engineering and finance departments. They will understand that a weak link in any department leaves the entire corporation vulnerable to FDA enforcement. And above all, attendees will also begin to apply the boundaries the FDA uses now and understand how easy it is to promote yourself into a corner.

Who Should Attend:


  • Sales and marketing executives and managers
  • Regulatory managers
  • In-house legal counsel and contract specialists
  • Third party consultants
  • Owners and executive managers of new or developing firms of new or developing firms
  • Own label distributors
  • International trade managers
  • Product specification developers

Key Topics Covered:

  • FDA labeling vis-a-vis promotion and advertising via social media
  • Direct to consumer marketing issues
  • Fair and balanced information considerations
  • Context of messaging and target population
  • Exemptions for social media use
  • Management roles and responsibilities

For more information about this webinar visit https://www.researchandmarkets.com/r/8cv6d


[ Back To TMCnet.com's Homepage ]